跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OCTASA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OCTASA
Authorized
STANDARD
OCTASA
Tillotts Pharma Ag
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9897cbc38aba62de
Company
Tillotts Pharma Ag
Type
Standard
Approval Details
Approval Id
9897cbc38aba62de
Drug Approval Canada Name
OCTASA
Product Name
OCTASA
Status
Marketed
Status Date
2023-03-02
Original Market Date
2023-03-02
Din
02529610
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:36.00
Atc Original
A07EC02 MESALAZINE
Atc Name
a 07 ec 02
Aig Number
0116808015
Company Name
Tillotts Pharma Ag
Company Address
Baslerstrasse 15, Rheinfelden, Aargau, Switzerland, 4310
Company Detail Path
/organization/tillotts-pharma-ag
Company Information
Pharmaceutical Company Name
Tillotts Pharma Ag
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Website
http://www.tillotts.com
Active Ingredients
MESALAZINE
1600 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9897cbc38aba62de
Type
Standard
Back to Health Canada Approvals